BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18695660)

  • 21. [Granulocytes transfusion for neutropenic patients].
    Fernández J; Pressiani V; Solimano J; Koziner B
    Medicina (B Aires); 2001; 61(1):93-104. PubMed ID: 11294144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte transfusion in children.
    Raj R; Kamath SR; Ranjit S; Shankar N; Lakshmanan V
    Indian Pediatr; 2009 Jun; 46(6):516-8. PubMed ID: 19179734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia.
    Teofili L; Valentini CG; Di Blasi R; Orlando N; Fianchi L; Zini G; Sica S; De Stefano V; Pagano L
    PLoS One; 2016; 11(8):e0159569. PubMed ID: 27487075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte transfusion: revisited.
    Briones MA; Josephson CD; Hillyer CD
    Curr Hematol Rep; 2003 Nov; 2(6):522-7. PubMed ID: 14561398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy.
    Hübel K; Engert A
    Onkologie; 2003 Feb; 26(1):73-9. PubMed ID: 12624522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections.
    Lee JJ; Song HC; Chung IJ; Bom HS; Cho D; Kim HJ
    Haematologica; 2004 May; 89(5):632-3. PubMed ID: 15136239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte transfusions in the G-CSF era. Where do we stand?
    Robinson SP; Marks DI
    Bone Marrow Transplant; 2004 Nov; 34(10):839-46. PubMed ID: 15273712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B.
    Bow EJ; Schroeder ML; Louie TJ
    Can Med Assoc J; 1984 Mar; 130(5):593-7. PubMed ID: 6697270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early granulocyte transfusions in high risk febrile neutropenic patients.
    Schweiz Med Wochenschr Suppl; 1983; 14():46-8. PubMed ID: 6361991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical application of granulocyte concentrates in neutropenia caused by immunosupressive treatment].
    Korsak J
    Pol Merkur Lekarski; 2008 Apr; 24(142):346-50. PubMed ID: 18634371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The role of granulocyte transfusions.
    Strauss RG
    Am J Pediatr Hematol Oncol; 1984; 6(3):247-53. PubMed ID: 6393788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes.
    Drewniak A; Boelens JJ; Vrielink H; Tool AT; Bruin MC; van den Heuvel-Eibrink M; Ball L; van de Wetering MD; Roos D; Kuijpers TW
    Haematologica; 2008 Jul; 93(7):1058-67. PubMed ID: 18508794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revisiting the use of granulocyte transfusions in pediatric oncology patients.
    Graham AS; Price TH; Brogan TV
    J Pediatr Hematol Oncol; 2009 Mar; 31(3):161-5. PubMed ID: 19262240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Granulocyte transfusion].
    Reikvam H; Blom US; Kristoffersen E; Liseth K; Bruserud O; Hervig T
    Tidsskr Nor Laegeforen; 2009 Feb; 129(5):416-9. PubMed ID: 19247402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte Transfusions: A Critical Reappraisal.
    Valentini CG; Farina F; Pagano L; Teofili L
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2034-2041. PubMed ID: 28797785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Navigating the neutropenic abyss with granulocyte transfusions: Retrospective single-center analysis of effectiveness and safety in India.
    Desai P; Navkudkar A; Bagal B; Dhamne C; Jain H; Sengar M; Chinnaswamy G; Nayak L
    J Clin Apher; 2023 Dec; 38(6):703-710. PubMed ID: 37560907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model.
    Dranitsaris G; Rayson D; Vincent M; Chang J; Gelmon K; Sandor D; Reardon G
    Am J Clin Oncol; 2008 Aug; 31(4):369-74. PubMed ID: 18845996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis.
    Weingarten C; Pliez S; Tschiedel E; Grasemann C; Kreissig C; Schündeln MM
    Eur J Pediatr; 2016 Oct; 175(10):1361-9. PubMed ID: 27631588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.
    Hübel K; Carter RA; Liles WC; Dale DC; Price TH; Bowden RA; Rowley SD; Chauncey TR; Bensinger WI; Boeckh M
    Transfusion; 2002 Nov; 42(11):1414-21. PubMed ID: 12421213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.